Prevention of restenosis using the gene for cecropin complexed with DOCSPER liposomes under optimized conditions

International Journal of Angiology

Volumn 9, Issue 2, 2000, Pages 87-94

  Nikol, Sigrid ^a   Pelisek, Jaroslav ^a   Engelmann, Markus G ^a   Rolland, Pierre H ^b   Armeanu, Sorin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinikum Großhadern ^*

Author keywords

[No Author keywords available]

Indexed keywords

CECROPIN; CECROPIN A; LIPOSOME; PLASMID DNA; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENE TARGETING; GENE TRANSFER; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RESTENOSIS; SWINE; TRANSGENE; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

EID: 0034116946     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01617047     Document Type: Article

References (36)

1. 1. Barker SG, Tilling LC, Miller GC, Beesley JE, Fleetwood G, Stavri GT, Buskerville PA, Martin JF (1994) The adventitia and atherogenesis: Removal initiates intimal proliferation in the rabbit which regresses on generation of a 'neoadventitia'. Atherosclerosis 105:131-44.
2. 2. Bauters C, Isner JM (1997) The biology of restenosis. Prog Cardiovasc Dis 40:107-116.
3. 3. Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13:61-92.
4. 4. Boman HG, Steiner H (1981) Humoral immunity in Cecropia pupae. Curr Top Microbiol Immunol 95:75-91.
5. 5. Chang MW, Barr E, Lu MM, Barton K, Leiden JM (1995) Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96:2260-2268.
6. 6. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM (1995) Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267:518-522.
7. 7. Gonschior P, Goetz AE, Huehns TY, Hofling B (1995) A new catheter for prolonged local drug application. Coron Artery Dis 6:329-334.
8. 8. Gonschior P, Pahl C, Huehns TY, Gerheuser F, Erdemci A, Larisch K, Dellian M, Deil S, Goetz AE, Lehr HA (1995) Comparison of local intravascular drug-delivery catheter systems. Am Heart J 130:1174-1181.
9. 9. Groth D, Keilb O, Lehmana C, Schneider M, Rudo M (1998) Preparation and characterisation of an new lipospermine for gene delivery into various cells. Int J Pharmaceutics 162:143-157.
10. 10. Hernandez VP, Gerenday A, Fallon AM (1994) Secretion of an inducible cecropin-like activity by cultured mosquito cells. Am J Trop Med Hyg 50:440-447.
11. 11. Hofling B, Huehns TY (1995) Intravascular local drug delivery after angioplasty. Eur Heart J 16:437-440.
12. 12. Huehns TY, Gonschior P, Höfling B (1996) Adventitia as a target for intravascular local drug delivery. Heart 75:437-438.
13. 13. Huehns TY, Krausz E, Mrochen S, Schmid M, Engelmann MG, Esin S, Schrittenloher PK, Höfling B, Günzburg WH, Nikol S (1999) Neo-intimal growth can be influenced by local advential gene delivery via a needle injection catheter. Athersclerosis 144:135-150.
14. 14. Hugosson M, Andreu D, Boman HG, Glaser E (1994) Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import. Eur J Biochem 223:1027-1033.
15. 15. Innis MA, Gelfand DH (1990) Optimization of PCRs. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (Eds.): PCR protocols: A guide to methods and applications. San Diego: Academic Press, pp. 84-91.
16. 16. Javadpour MM, Juban MM, Lo WC, Bishop SM, Alberty JB, Cowell SM (1996) De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem 39:3107-3113.
17. 17. Jaynes JM, Julian GR, Jeffers GW, White KL, Enright FM (1989) In vitro cytocidal effect of lytic peptides on several transformed mammalian cell lines. Pept Res 2:157-160.
18. 18. Keogh MC, Chen D, Lupu F, Shaper N, Schmitt JE, Kakkar W, Lemoine N (1997) High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid dna complex. Gene Therapy 4:162-171.
19. 19. Moore AJ, Devine DA, Bibby MC (1994) Preliminary experimental anticancer activity of cecropins. Pept Res 7:265-269.
20. 20. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ (1995) A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 92: 5855-5859.
21. 21. Nabel EG, Plautz G, Nabel GJ (1990) Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249:1285-1288.
22. 22. Nakata Y, Shionoya S (1966) Vascular lesions due to obstruction of the vasa vasorum. Nature 212:1258-1259.
23. 23. Nikol S (1996) Induction of neointimal formation by local gene transfer of the antisense senscent-cell-derived inhibitor 1 (SDI) delivered with the needle injection catheter. J Am Coll Cardiol 24(suppl):289A.
24. 24. Nikol S, Huehns TY, Hofling B (1996) Molecular biology and post angioplasty restenosis. Atherosclerosis 123:17-31.
25. 25. Nikol S, Huehns TY, Krausz E, Armeanu S, Engelmann MG, Winder D, Salmons B, Höfling B (1999) Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation. Gene Therapy 6:737-748.
26. 26. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ (1994) Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265:781-784.
27. 27. Reszka R (1997) Therapeutic and immunohistochemical evaluation of suicide gene transfer in an rat F98 glioblastoma model: Liposomal approach versus viral delivery. Proceedings of the 3rd International workshop on Gene Transfer in Hematology and Oncology (Abstract).
28. 28. Schwartz RS, Holmes DJ (1992) The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 20:1284-1293.
29. 29. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489-495.
30. 30. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A (1996) Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94:1655-1664.
31. 31. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD (1992) Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359:67-70.
32. 32. Tahlil O, Brami M, Feldman LJ, Branellec D, Steg PG (1997) The dispatch catheter as a delivery tool for arterial gene transfer. Cardiovasc Res 33:181-187.
33. 33. Winder D, Gunzburg WH, Erfle V, Salmons B (1998) Expression of antimicrobial peptides has an antitumour effect in human cells. Biochem Biophys Res Commun 242:608-612.
34. 34. Wolinsky H, Thung SN (1990) Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 15:475-481.
35. 35. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG (1996) Role of the p21 cyclin dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA 93:7905-7910.
36. 36. Yonemitsu Y, Kaneda Y, Tanaka S, Nakashima Y, Komori K, Sugimachi K, Sueishi K (1998) Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82:147-156.